卖什么
Pioneering Breast Cancer Diagnostics for a Healthier Tomorrow
商业模式拆解
买家：谁掌握预算？
未核实Hospital oncology/pathology departments and multidisciplinary teams (clinician-ordered in vitro diagnostic).
触发点：什么让他们现在购买？
Post-surgery decision on recurrence risk and whether to escalate treatment.
工作流：什么输入变成什么输出？
Tumour tissue analysed by infrared spectrometry to produce Digistain Index, combined with clinicopathological features in a validated multivariate model to give a Digistain Prognostic Score for MDT discussion.
经济账：省了什么，怎么收费？
未核实Per-test diagnostic service/IVD; claims validation in a retrospective cohort of 801 patients with 12.7 years median follow-up.
渠道：怎么接触到客户？
Clinician-facing, contact-led; UKCA-marked, MHRA registered.
融资历史与报道
| 融资日期 | 轮次 | 金额 | 投资方 | 来源 |
|---|---|---|---|---|
| — | YC 2021 夏季 | — | Y Combinator | ycombinator.com |
档案汇总自公开报道和公司官网。商业模式部分是 MaxBC 对这些材料的解读，不是已确认的事实；未知之处留空，不作猜测。 更新于 2026-10-12.